Summary of the Truly Agreed Version of the Bill

CCS SB 1068 -- PHARMACY AUDITS, PHARMACY REBATES FUND, AND
FIBROMYALGIA AWARENESS

This bill establishes guidelines for pharmacy audits, creates the
Pharmacy Rebates Fund, and establishes the Missouri Fibromyalgia
Awareness Initiative Program.

PHARMACY AUDITS

The bill establishes guidelines that entities must follow when
auditing a pharmacy.  Any entity conducting an audit must develop
an appeal process under which a pharmacy can appeal an
unfavorable audit report.  The bill does not apply to any
investigative audits involving fraud, willful misrepresentation,
or abuse.

PHARMACY REBATES FUND

The Pharmacy Rebates Fund is created to be used in the MO
HealthNet Pharmacy Program.  Any money received by the state from
pharmaceutical manufacturer rebates as required by federal law or
state supplemental rebates as specified in State Medicaid Plan
amendments must be deposited into the fund and can only be used
in the program.

MISSOURI FIBROMYALGIA AWARENESS INITIATIVE PROGRAM

The bill establishes the Missouri Fibromyalgia Awareness
Initiative Program within the Department of Health and Senior
Services and requires the department to establish the Missouri
Fibromyalgia Panel and provide the program and the panel with the
necessary administrative services and support.  The panel will be
comprised of volunteers with knowledge and expertise regarding
fibromyalgia research, prevention, educational programs, and
consumer needs to guide program development.  The panel is
required to:

(1)  Seek and accept private, federal, or other public financial
support, grants, or other appropriate funds to support the
program;

(2)  Consult with the National Fibromyalgia Association to raise
at least $50,000 through private funding to establish a public
information and outreach campaign for issues related to
fibromyalgia;

(3)  Work with other state and local agencies to promote
fibromyalgia education and training programs for physicians and
health professionals; and

(4)  Examine various pharmaceutical treatments available for
fibromyalgia patients.

The provisions regarding the program and the panel will only be
implemented if the panel obtains the required private funding.

Copyright (c) Missouri House of Representatives


Missouri House of Representatives
94th General Assembly, 2nd Regular Session
Last Updated October 15, 2008 at 3:13 pm